Company / Net Debt per Share
Astria Therapeutics, Inc. Net Debt per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$6.40
FY2017
5-year range
-
FY2016-FY2017
Trend
-484.5%
vs FY2016
Sector context
#79 of 82
Health Care
What the data says
Among 82 Health Care companies, Astria Therapeutics, Inc. is in the top 4% for net debt per share.
Based on SEC 10-K filings.
-6.40 in FY2017.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 82This company -$6.40 Sector average $13.70
▼
-146.7% below sector average
Key checks
Key Insights
- In FY2017, net debt per share decreased 484.5% year-over-year.
- Ranks #79 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -$6.40 | -484.5% |
| FY2016 | -$1.09 | - |
| FY2015 | - | - |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026